|Articles|March 1, 2018
- Pharmaceutical Executive-03-01-2018
- Volume 38
- Issue 3
Pharmaceutical Executive, March 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive March 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Pharma: Meet Your New Neighborsover 7 years ago
Risk Sharing, Italian Styleover 7 years ago
The Quest to Measure Upover 7 years ago
Full Disclosure Demanded for Pharma Industryover 7 years ago
Setting the Standard: William Soliman, ACMAover 7 years ago
The Law of Unintended Consequencesover 7 years ago
Pricing Turning Point: The Case for Innovating Pharma’s Modelover 7 years ago
Showdown Nears on Europe Research Incentivesover 7 years ago
The Personalized Genetic Profile: It’s Time to Alignover 7 years ago
Country Report: IndiaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
How are the Drug Pricing Negotiations Impacting Pharma's Relationship with DC?
2
Excellergy Announces Launch with $70 Million Series A Funding Aiming to Advance Pipeline of Trifunctional Effector Cell Response Inhibitors
3
Policy Whiplash in Pharma: Navigating Volatility with Strategic Clarity
4
